TRIPACEL HYBRID
TRIPACEL HYBRID
Discontinued
DIN Number
02224143
Drug Class
Human
Market Date
Jan 23, 1997
Company
HC
Sanofi Pasteur Limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02224143
AIG Number0628682001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07AJ52 PERTUSSIS, PURIFIED ANTIGEN, COMB. WITH TOXOIDS
Product Specifications
Dosage FormSuspension
Route of AdministrationIntramuscular
AHFS Classification80:08.00
Health Canada Classification
ACTIVE INGREDIENTS (6)
DIPHTHERIA TOXOIDActive
Strength: 15 LF / 0.5 ML
Monograph: DIPHTHERIA TOXOID
FILAMENTOUS HAEMAGGLUTININActive
Strength: 20 MCG / 0.5 ML
Monograph: FILAMENTOUS HAEMAGGLUTININ
FIMBRIAEActive
Strength: 5 MCG / 0.5 ML
Monograph: FIMBRIAE
PERTACTINActive
Strength: 3 MCG / 0.5 ML
Monograph: PERTACTIN
PERTUSSIS TOXOIDActive
Strength: 20 MCG / 0.5 ML
Monograph: PERTUSSIS TOXOID
TETANUS TOXOIDActive
Strength: 5 LF / 0.5 ML
Monograph: TETANUS TOXOID